Scarica l'app Stockscreener
1.55
6.63%
-0.11
Dopo l'orario di chiusura:
1.59
0.04
+2.58%
Precedente Chiudi:
$1.66
Aprire:
$1.61
Volume 24 ore:
2.19M
Relative Volume:
1.77
Capitalizzazione di mercato:
$411.17M
Reddito:
-
Utile/perdita netta:
$-208.38M
Rapporto P/E:
-1.2917
EPS:
-1.2
Flusso di cassa netto:
$-156.57M
1 W Prestazione:
-9.36%
1M Prestazione:
-10.40%
6M Prestazione:
-57.30%
1 anno Prestazione:
-75.71%
Intervallo 1D:
$1.52
$1.63
Intervallo di 1 settimana:
$1.52
$1.73
Portata 52W:
$1.52
$6.31
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Nome
Autolus Therapeutics Plc Adr
Settore
Industria
Telefono
44 20 3829 6230
Indirizzo
THE MEDIAWORKS, LONDON
Confronta AUTL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.55 | 411.17M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-18 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-11-15 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Buy |
| 2023-03-27 | Ripresa | Wells Fargo | Overweight |
| 2023-03-17 | Iniziato | Bryan Garnier | Buy |
| 2021-06-14 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-01-29 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Ripresa | H.C. Wainwright | Buy |
| 2020-07-31 | Iniziato | JP Morgan | Overweight |
| 2020-07-22 | Iniziato | SunTrust | Buy |
| 2020-04-22 | Iniziato | Mizuho | Buy |
| 2019-09-23 | Iniziato | Needham | Buy |
| 2019-05-17 | Reiterato | H.C. Wainwright | Buy |
| 2018-10-24 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Autolus Therapeutics Plc Adr Borsa (AUTL) Ultime notizie
Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India
Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa
Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register
Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa
Mizuho maintains $12 target on Autolus stock after Q4 update - Investing.com India
Autolus reports progress in commercial launch and financials By Investing.com - Investing.com South Africa
Truist maintains $11 target on Autolus stock amid strong demand - Investing.com India
Autolus reports progress in commercial launch and financials - Investing.com India
Earnings call transcript: Autolus Therapeutics Q4 2024 earnings and market reaction By Investing.com - Investing.com South Africa
Autolus Therapeutics to Report Fourth Quarter 2024 Financial Results and Host Conference Call on March 20, 2025 - GlobeNewswire Inc.
10 Best UK Growth Stocks to Buy Now - Insider Monkey
Stock Surge: Autolus Therapeutics plc ADR (AUTL) Closes at 1.82, Marking a 1.68 Increase/Decrease - The Dwinnex
It would be worthwhile to take a closer look at Autolus Therapeutics plc ADR (AUTL) - US Post News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Autolus Therapeutics plc ADR [AUTL] Officer makes an insider purchase of 698,741 shares worth 2.96 million. - Knox Daily
Lowe’s Cos., Inc Inc. (LOW) Price Performance: The Role of Supply and Demand - The InvestChronicle
Avinger Inc [AVGR] Records 50-Day SMA of $0.7054 - Knox Daily
Floor & Decor Holdings Inc [FND] Shares Rise 0.52 % on Thursday - Knox Daily
GS Shares Experience Surge in Value - Knox Daily
Crown Holdings, Inc [CCK] Shares Fall Approximately -1.11% Over the Year - Knox Daily
VRDN Stock Sees Decline of Approximately -7.82% in Last Five Days - Knox Daily
There is no doubt that Nurix Therapeutics Inc (NRIX) ticks all the boxes. - SETE News
Enovis Corp (ENOV) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
You might want to take a look at Autolus Therapeutics plc ADR (AUTL) now - SETE News
Clean Energy Fuels Corp (CLNE)’s stock rises to 3.45 per share - US Post News
Adc Therapeutics SA (ADCT) stock analysis: A comprehensive overview - US Post News
GH Research PLC (GHRS) stock: A year of ups and downs - US Post News
Calumet Inc (CLMT)’s stock price range in the last year - US Post News
A closer look at Autolus Therapeutics plc ADR (AUTL)’s stock price trends - US Post News
Quarterly Snapshot: Quick and Current Ratios for Autolus Therapeutics plc ADR (AUTL) - The Dwinnex
Balance Sheet Insights: Edison International (EIX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Selling Your Standard Lithium Ltd (AMEX: SLI) Stock? Here’s What You Need To Know - Stocks Register
Autolus presents new data on CAR-T therapy cost benefits - Investing.com
Autolus' AUCATZYL Shows Superior Cost-Effectiveness and 84% Deep Remission Rate in Latest Data - StockTitan
A Stock Analysis Of Autolus Therapeutics plc ADR’s (AUTL) - Stocks Register
MicroAlgo Inc’s (MLGO) -2.91% Drop Is A Reason To Reconsider. - Stocks Register
Aspen Aerogels Inc (ASPN) Strikes $14.34: The Risk Seems Worthwhile At This Price - Stocks Register
Autolus reports high response in leukemia study - Investing.com India
CommScope Holding Company Inc (COMM) Is A Good Investment At Current Valuations - Stocks Register
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocks Register
These Numbers Prove Just How Vibrant The Ocugen Inc (NASDAQ: OCGN) Stock Has Been - Stocks Register
Autolus stock upgraded as obe-cel approval drives optimism for commercial potential - Investing.com
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - Barchart
FDA approves new CAR-T competitor to Gilead’s Tecartus - BioPharma Dive
Does MP Materials Corporation (NYSE: MP) Still Need To Convince Analysts? - Stocks Register
Hafnia Ltd (NYSE: HAFN) Drops -3.00%, Turning Investors Away - Stocks Register
Autolus Therapeutics (AUTL): High-Growth UK Stock in Cancer Therapy - Yahoo Finance
Why Autolus Therapeutics plc (AUTL) is the Penny Stock with the Biggest Upside Potential According to Analysts - Yahoo Finance
PDD Holdings Inc ADR (NASDAQ: PDD) Has Been Trading Down. What Are The Prospects For The Future? - Stocks Register
Autolus Therapeutics Plc Adr Azioni (AUTL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.05%
1.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):